Lyell Immunopharma, Inc. (LYEL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Lynn Seely, President and CEO of Lyell Therapeutics. Question-and-Answer Session Unknown Analyst Lynn, to start here, could you give us an overview of where your two oncology programs stand today and how to think about the catalyst path as we look to second half and beyond?
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Lynn Seely, President and CEO of Lyell Therapeutics.
- ▪Question-and-Answer Session Unknown Analyst Lynn, to start here, could you give us an overview of where your two oncology programs stand today and how to think about the catalyst path as we look to second half and beyond?
Seeking Alpha files mainly under finance. We currently carry 6,509 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4913722-lyell-immunopharma-inc-lyel-presents-at-goldman-sachs-47th-annual-global-healthcare"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"https://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
